Tracer CRO

TRACER is a specialized Clinical Research Organization (CRO) focused on providing fast-track clinical proof-of-concept for drug development through advanced molecular imaging. The company utilizes nuclear imaging techniques, such as PET and SPECT, to visualize and quantify the biodistribution and target engagement of novel compounds in humans at an early stage. By leveraging 'cold' and 'hot' labeling of drugs, TRACER enables pharmaceutical and biotech companies to generate high-quality human data, potentially reducing the time and cost of drug development. Their services span from preclinical labeling strategy to Phase I and II clinical trial execution, with a particular emphasis on oncology and infectious diseases.